Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Zhiqinghe Tea Tech is a specialized biotechnology company focused on the research, development, and commercialization of functional tea-derived compounds for metabolic health. The company utilizes advanced extraction and fermentation technologies to produce bioactive substances such as tea polyphenols, theaflavins, and specific tea-derived peptides aimed at managing blood glucose and lipid levels. Their flagship products are positioned as medical-grade functional foods and nutraceuticals targeting populations with pre-diabetes and metabolic syndrome. By bridging traditional tea science with modern pharmacology, Zhiqinghe provides evidence-based natural solutions for weight management and endocrine health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Zhiqinghe Tea Tech.